Combined inhibition of IL-6 and IL-8 pathways suppresses ovarian cancer cell viability and migration and tumor growth

por Zhang, Ruijie, Roque, Dana M., Reader, Jocelyn, Lin, Jiayuh
Publicado 2022

A novel small molecule LLL12B inhibits STAT3 signaling and sensitizes ovarian cancer cell to paclitaxel and cisplatin

por Zhang, Ruijie, Yang, Xiaozhi, Roque, Dana M., Li, Chenglong, Lin, Jiayuh
Publicado 2021

Microtubule-Interfering Drugs: Current and Future Roles in Epithelial Ovarian Cancer Treatment

por Tymon-Rosario, Joan, Adjei, Naomi N., Roque, Dana M., Santin, Alessandro D.
Publicado 2021

Clinical Outcomes of Intensity Modulated Proton Therapy Reirradiation for Gynecologic Malignancies

por Pollock, Ariel E., Risher, Hunter, Berger, Melanie, Roque, Dana M., Rao, Gautam, Nichols, Elizabeth M., Mohindra, Pranshu
Publicado 2023

Evolutionary dynamics of cancer multidrug resistance in response to olaparib and photodynamic therapy

por Baglo, Yan, Sorrin, Aaron J., Pu, Xiaocong, Liu, Cindy, Reader, Jocelyn, Roque, Dana M., Huang, Huang-Chiao
Publicado 2021

Photodynamic Priming Improves the Anti-Migratory Activity of Prostaglandin E Receptor 4 Antagonist in Cancer Cells In Vitro

por Sorrin, Aaron J., Liu, Cindy, Cicalo, Julia, Reader, Jocelyn, Najafali, Daniel, Zhang, Yuji, Roque, Dana M., Huang, Huang-Chiao
Publicado 2021

EP4 and Class III β-Tubulin Expression in Uterine Smooth Muscle Tumors: Implications for Prognosis and Treatment

por Reader, Jocelyn, Harper, Amy K., Legesse, Teklu, Staats, Paul N., Goloubeva, Olga, Rao, Gautam G., Fulton, Amy, Roque, Dana M.
Publicado 2019

Transient fluid flow improves photoimmunoconjugate delivery and photoimmunotherapy efficacy

por Sorrin, Aaron J., Zhou, Keri, May, Katherine, Liu, Cindy, McNaughton, Kathryn, Rahman, Idrisa, Liang, Barry J., Rizvi, Imran, Roque, Dana M., Huang, Huang-Chiao
Publicado 2023

Selective targeting of metastatic ovarian cancer using an engineered anthrax prodrug activated by membrane-anchored serine proteases

por Duru, Nadire, Pawar, Nisha R., Martin, Erik W., Buzza, Marguerite S., Conway, Gregory D., Lapidus, Rena G., Liu, Shihui, Reader, Jocelyn, Rao, Gautam G., Roque, Dana M., Leppla, Stephen H., Antalis, Toni M.
Publicado 2022

Trop-2 protein overexpression is an independent marker for predicting disease recurrence in endometrioid endometrial carcinoma

por Bignotti, Eliana, Zanotti, Laura, Calza, Stefano, Falchetti, Marcella, Lonardi, Silvia, Ravaggi, Antonella, Romani, Chiara, Todeschini, Paola, Bandiera, Elisabetta, Tassi, Renata A, Facchetti, Fabio, Sartori, Enrico, Pecorelli, Sergio, Roque, Dana M, Santin, Alessandro D
Publicado 2012

Fluorescence-guided photoimmunotherapy using targeted nanotechnology and ML7710 to manage peritoneal carcinomatosis

por Liang, Barry J., Pang, Sumiao, Perttila, Robert, Ma, Chen-Hua, Srivastava, Payal, Gaitan, Brandon, Sorrin, Aaron J., Fadul, Nada, Rahman, Idrisa, Ylo¨niemi, Zoe, Roque, Dana M., Hasan, Tayyaba, Uusimaa, Petteri, Huang, Huang-Chiao
Publicado 2023

Secretoglobin expression in ovarian carcinoma: lipophilin B gene upregulation as an independent marker of better prognosis

por Bignotti, Eliana, Tassi, Renata A, Calza, Stefano, Ravaggi, Antonella, Rossi, Elisa, Donzelli, Carla, Todeschini, Paola, Romani, Chiara, Bandiera, Elisabetta, Zanotti, Laura, Carnazza, Mario, Quadraro, Francesco, Tognon, Germana, Sartori, Enrico, Pecorelli, Sergio, Roque, Dana M, Santin, Alessandro D
Publicado 2013

Malignant Ascites in Ovarian Cancer: Cellular, Acellular, and Biophysical Determinants of Molecular Characteristics and Therapy Response

por Rickard, Brittany P., Conrad, Christina, Sorrin, Aaron J., Ruhi, Mustafa Kemal, Reader, Jocelyn C., Huang, Stephanie A., Franco, Walfre, Scarcelli, Giuliano, Polacheck, William J., Roque, Dana M., del Carmen, Marcela G., Huang, Huang-Chiao, Demirci, Utkan, Rizvi, Imran
Publicado 2021

Microtentacle Formation in Ovarian Carcinoma

por Reader, Jocelyn C., Fan, Cong, Ory, Eleanor Claire-Higgins, Ju, Julia, Lee, Rachel, Vitolo, Michele I., Smith, Paige, Wu, Sulan, Ching, Mc Millan Nicol, Asiedu, Emmanuel B., Jewell, Christopher M., Rao, Gautam G., Fulton, Amy, Webb, Tonya J., Yang, Peixin, Santin, Alessandro D., Huang, Huang-Chiao, Martin, Stuart S., Roque, Dana M.
Publicado 2022

Randomised phase II trial of weekly ixabepilone ± biweekly bevacizumab for platinum-resistant or refractory ovarian/fallopian tube/primary peritoneal cancer

por Roque, Dana M., Siegel, Eric R., Buza, Natalia, Bellone, Stefania, Silasi, Dan-Arin, Huang, Gloria S., Andikyan, Vaagn, Clark, Mitchell, Azodi, Masoud, Schwartz, Peter E., Rao, Gautam G., Reader, Jocelyn C., Hui, Pei, Tymon-Rosario, Joan R., Harold, Justin, Mauricio, Dennis, Zeybek, Burak, Menderes, Gulden, Altwerger, Gary, Ratner, Elena, Santin, Alessandro D.
Publicado 2022